Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Issa, Khodor ^a,b   Kimmoun, Antoine ^a,b,c   Collin, Solène ^a,b,c   Ganster, Frederique ^a   Fremont Orlowski, Sophie ^a,b,c   Asfar, Pierre ^d   Mertes, Paul Michel ^a,b,c   Levy, Bruno ^a,b,c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c CHU NANCY BRABOIS   (France)

^d UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA AESAR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; POTASSIUM CHANNEL; PROPARGYLGLYCINE; PROTEIN KINASE B; SODIUM HYDROSULFIDE; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; ADAMANTANE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALKYNE; CYTOKINE; GASOTRANSMITTER; GLYCINE; MITOGEN ACTIVATED PROTEIN KINASE 9; MORPHOLINE DERIVATIVE; NORADRENALIN; SODIUM BISULFIDE; SULFIDE; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; BLOOD VESSEL REACTIVITY; CELL ACTIVATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EX VIVO STUDY; HEMODYNAMICS; HEMORRHAGIC SHOCK; INDUCED HYPOTENSION; LACTIC ACIDOSIS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; UPREGULATION; WISTAR RAT;

ACIDOSIS, LACTIC; ADAMANTANE; ADENOSINE TRIPHOSPHATE; ALKYNES; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; GASOTRANSMITTERS; GLYCINE; HEMODYNAMICS; HYDROGEN SULFIDE; KATP CHANNELS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MORPHOLINES; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS, WISTAR; REPERFUSION INJURY; SHOCK, HEMORRHAGIC; SULFIDES; UP-REGULATION; VASOCONSTRICTOR AGENTS;

EID: 84880000787     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12808     Document Type: Article

References (30)

1. Altavilla D, Saitta A, Guarini S, Galeano M, Squadrito G, Cucinotta D, Santamaria LB, Mazzeo AT, Campo GM, Ferlito M, Minutoli L, Bazzani C, Bertolini A, Caputi AP, Squadrito F. Oxidative stress causes nuclear factor-kappaB activation in acute hypovolemic hemorrhagic shock. Free Radic Biol Med 2001, 30:1055-1066. 10.1016/S0891-5849(01)00492-0, 11369495.
2. Hierholzer C, Menezes JM, Ungeheuer A, Billiar TR, Tweardy DJ, Harbrecht BG. A nitric oxide scavenger protects against pulmonary inflammation following hemorrhagic shock. Shock 2002, 17:98-103. 10.1097/00024382-200202000-00003, 11837796.
3. Hua TC, Moochhala SM. Role of nitric oxide in hemorrhagic shock-induced bacterial translocation. J Surg Res 2000, 93:247-256. 10.1006/jsre.2000.5991, 11027467.
4. Smail N CR, Wang P, Cioffi WG, Bland KI, Chaudry IH. Gut and liver: the organs responsible for increased nitric oxide production after trauma-hemorrhage and resuscitation. Arch Surg 1998, 133:399-405. 10.1001/archsurg.133.4.399, 9565120.
5. Md S, Moochhala SM, Siew Yang KL, Lu J, Anuar F, Mok P, Ng KC. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats. J Surg Res 2005, 123:206-214. 10.1016/j.jss.2004.07.243, 15680380.
6. Liu YH, Lu M, Hu LF, Wong PT, Webb GD, Bian JS. Hydrogen sulfide in the mammalian cardiovascular system. Antioxid Redox Signal 2012, 17:141-185. 10.1089/ars.2011.4005, 22304473.
7. Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C. Bench-to-bedside review: hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care 2009, 13:213. 10.1186/cc7700, 2717401, 19519960.
8. Morrison ML, Blackwood JE, Lockett SL, Iwata A, Winn RK, Roth MB. Surviving blood loss using hydrogen sulfide. J Trauma 2008, 65:183-188. 10.1097/TA.0b013e3181507579, 18580516.
9. Ganster F, Burban M, de la Bourdonnaye M, Fizanne L, Douay O, Loufrani L, Mercat A, Cales P, Radermacher P, Henrion D, Asfar P, Meziani F. Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care 2010, 14:R165. 3219260, 20836847.
10. Gao C, Xu DQ, Gao CJ, Ding Q, Yao LN, Li ZC, Chai W. An exogenous hydrogen sulphide donor, NaHS, inhibits the nuclear factor kappaB inhibitor kinase/nuclear factor kappab inhibitor/nuclear factor-kappaB signaling pathway and exerts cardioprotective effects in a rat hemorrhagic shock model. Biol Pharm Bull 2012, 35:1029-1034. 10.1248/bpb.b110679, 22791148.
11. Chai W, Wang Y, Lin JY, Sun XD, Yao LN, Yang YH, Zhao H, Jiang W, Gao CJ, Ding Q. Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress. J Surg Res 2012, 176:210-219. 10.1016/j.jss.2011.07.016, 21962736.
12. Bracht H, Scheuerle A, Groger M, Hauser B, Matallo J, McCook O, Seifritz A, Wachter U, Vogt JA, Asfar P, Matejovic M, Moller P, Calzia E, Szabo C, Stahl W, Hoppe K, Stahl B, Lampl L, Georgieff M, Wagner F, Radermacher P, Simon F. Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock. Crit Care Med 2012, 40:2157-2167. 10.1097/CCM.0b013e31824e6b30, 22713217.
13. Drabek T, Kochanek PM, Stezoski J, Wu X, Bayir H, Morhard RC, Stezoski SW, Tisherman SA. Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs. Shock 2011, 35:67-73. 10.1097/SHK.0b013e3181e86f49, 20523266.
14. Mok YY, Moore PK. Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflamm Res 2008, 57:512-518. 10.1007/s00011-008-7231-6, 19109743.
15. Mok YY, Atan MS, Yoke Ping C, Zhong Jing W, Bhatia M, Moochhala S, Moore PK. Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 2004, 143:881-889. 10.1038/sj.bjp.0706014, 1575944, 15504752.
16. Groeger M, Matallo J, McCook O, Wagner F, Wachter U, Bastian O, Gierer S, Reich V, Stahl B, M HL, Szabo C, Georgieff M, Radermacher P, Calzia E, Wagner K. Temperature and cell-type dependency of sulfide-effects on mitochondrial respiration. Shock 2012, 38:367-374. 10.1097/SHK.0b013e3182651fe6, 22777116.
17. Wang R. Signaling pathways for the vascular effects of hydrogen sulfide. Curr Opin Nephrol Hypertens 2011, 20:107-112. 10.1097/MNH.0b013e3283430651, 21301337.
18. Whiteman M, Moore PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?. J Cell Mol Med 2009, 13:488-507. 10.1111/j.1582-4934.2009.00645.x, 19374684.
19. Wagner F, Scheuerle A, Weber S, Stahl B, McCook O, Knoferl MW, Huber-Lang M, Seitz DH, Thomas J, Asfar P, Szabo C, Moller P, Gebhard F, Georgieff M, Calzia E, Radermacher P, Wagner K. Cardiopulmonary, histologic, and inflammatory effects of intravenous Na2S after blunt chest trauma-induced lung contusion in mice. J Trauma 2011, 71:1659-1667. 10.1097/TA.0b013e318228842e, 21857260.
20. Wagner K, Georgieff M, Asfar P, Calzia E, Knoferl MW, Radermacher P. Of mice and men (and sheep, swine etc.): the intriguing hemodynamic and metabolic effects of hydrogen sulfide (H2S). Crit Care 2011, 15:146. 10.1186/cc10079, 3219339, 21489331.
21. Croker B, Crozat K, Berger M, Xia Y, Sovath S, Schaffer L, Eleftherianos I, Imler JL, Beutler B. ATP-sensitive potassium channels mediate survival during infection in mammals and insects. Nat Genet 2007, 39:1453-1460. 10.1038/ng.2007.25, 18026101.
22. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005, 365:63-78. 10.1016/S0140-6736(04)17667-8, 15639681.
23. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364:545-548. 10.1016/S0140-6736(04)16815-3, 15302200.
24. Surapisitchat J, Hoefen RJ, Pi X, Yoshizumi M, Yan C, Berk BC. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members. Proc Natl Acad Sci USA 2001, 98:6476-6481. 10.1073/pnas.101134098, 33493, 11353829.
25. Keegan PM, Wilder CL, Platt MO. Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte-endothelial cell signaling and JNK activation. Mol Cell Biochem 2012, 367:65-72. 10.1007/s11010-012-1320-0, 3390414, 22562303.
26. Van de Louw A, Haouzi P. Oxygen deficit and H2S in hemorrhagic shock in rats. Crit Care 2012, 16:R178. 10.1186/cc11661, 3682279, 23031430.
27. Calzia E, Radermacher P, Olson KR. Endogenous H2S in hemorrhagic shock: innocent bystander or central player?. Crit Care 2012, 16:183. 10.1186/cc11833, 23194072.
28. Bos EM, Leuvenink HG, Snijder PM, Kloosterhuis NJ, Hillebrands JL, Leemans JC, Florquin S, van Goor H. Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 2009, 20:1901-1905. 10.1681/ASN.2008121269, 2736772, 19628669.
29. Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 2009, 120:888-896. 10.1161/CIRCULATIONAHA.108.833491, 2768477, 19704099.
30. Wagner F, Wagner K, Weber S, Stahl B, Knoferl MW, Huber-Lang M, Seitz DH, Asfar P, Calzia E, Senftleben U, Gebhard F, Georgieff M, Radermacher P, Hysa V. Inflammatory effects of hypothermia and inhaled H2S during resuscitated, hyperdynamic murine septic shock. Shock 2011, 35:396-402. 10.1097/SHK.0b013e3181ffff0e, 20938376.